These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella. Nascimento Silva JR; Camacho LA; Siqueira MM; Freire Mde S; Castro YP; Maia Mde L; Yamamura AM; Martins RM; Leal Mde L; Vaccine; 2011 Aug; 29(37):6327-34. PubMed ID: 21640779 [TBL] [Abstract][Full Text] [Related]
5. Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy. Nash ER; Brand M; Chalkias S J Travel Med; 2015; 22(4):279-81. PubMed ID: 25922988 [TBL] [Abstract][Full Text] [Related]
6. Yellow fever vaccination: how much is enough? Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112 [TBL] [Abstract][Full Text] [Related]
7. Awareness of Inadvertent Use of Yellow Fever Vaccine Among Recipients of Renal Transplant. Miranda LJC; Agena F; Sartori AMC; David-Neto E; Azevedo LS; Pierrotti LC Transplant Proc; 2020 Jun; 52(5):1291-1293. PubMed ID: 32505502 [TBL] [Abstract][Full Text] [Related]
8. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Suzano CE; Amaral E; Sato HK; Papaiordanou PM; Vaccine; 2006 Feb; 24(9):1421-6. PubMed ID: 16236402 [TBL] [Abstract][Full Text] [Related]
9. Yellow fever vaccination coverage among children in Brazilian capitals. Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ; Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878 [TBL] [Abstract][Full Text] [Related]
10. Administration of yellow fever vaccine in patients with egg allergy. Rutkowski K; Ewan PW; Nasser SM Int Arch Allergy Immunol; 2013; 161(3):274-8. PubMed ID: 23548550 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study. Kernéis S; Launay O; Ancelle T; Iordache L; Naneix-Laroche V; Méchaï F; Fehr T; Leroy JP; Issartel B; Dunand J; van der Vliet D; Wyplosz B; Consigny PH; Hanslik T Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1522-8. PubMed ID: 23554297 [TBL] [Abstract][Full Text] [Related]
12. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX. Kitchener S Vaccine; 2004 Jun; 22(17-18):2103-5. PubMed ID: 15149765 [TBL] [Abstract][Full Text] [Related]
13. Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania. Schönenberger S; Hatz C; Bühler S J Travel Med; 2016 May; 23(5):. PubMed ID: 27296582 [TBL] [Abstract][Full Text] [Related]
14. Review of the risks and benefits of yellow fever vaccination including some new analyses. Monath TP Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029 [TBL] [Abstract][Full Text] [Related]
15. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response. Blom K; Braun M; Ivarsson MA; Gonzalez VD; Falconer K; Moll M; Ljunggren HG; Michaëlsson J; Sandberg JK J Immunol; 2013 Mar; 190(5):2150-8. PubMed ID: 23338234 [TBL] [Abstract][Full Text] [Related]
16. Duration of post-vaccination immunity against yellow fever in adults. Collaborative group for studies on yellow fever vaccines Vaccine; 2014 Sep; 32(39):4977-84. PubMed ID: 25090646 [TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program. Collaborative Group for Studies with Yellow Fever Vaccine Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925 [TBL] [Abstract][Full Text] [Related]